XOMA Royalty (XOMA) EBT Margin Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.49 Mn |
-60.59 Mn |
- |
-2,292.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,292.00 |
| Dec 31, 2025 |
-201,732.00 |
| Sep 30, 2025 |
7.52 Mn |
| Jun 30, 2025 |
29,548.00 |
| Mar 31, 2025 |
76,756.00 |
| Dec 31, 2024 |
304,451.00 |
| Sep 30, 2024 |
-6.83 Mn |
| Jun 30, 2024 |
59,756.00 |
| Mar 31, 2024 |
161,884.00 |
| Dec 31, 2023 |
-66,961.00 |
| Sep 30, 2023 |
27,217.00 |
| Jun 30, 2023 |
-38,090.00 |
| Mar 31, 2023 |
-226,077.00 |
| Dec 31, 2022 |
-1.54 Mn |
| Sep 30, 2022 |
-49,749.00 |
| Jun 30, 2022 |
-23,666.00 |
| Mar 31, 2022 |
189,967.00 |
| Dec 31, 2021 |
1.49 Mn |
| Sep 30, 2021 |
-27,856.00 |
| Jun 30, 2021 |
54,744.00 |
